Ameriprise Financial, Inc. 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 10:56 am Sale |
2021-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
AMERIPRISE FINANCIAL INC AMP |
285 0.000% |
-2,370,951 (-99.99%) |
Filing |
| 2021-02-12 12:08 pm Purchase |
2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
AMERIPRISE FINANCIAL INC AMP |
2,371,236 7.500% |
1,221,658 (+106.27%) |
Filing |